PFS Partners’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Hold |
79,000
| – | – | 0.22% | 40 |
|
|
2025
Q1 | $497K | Hold |
79,000
| – | – | 0.26% | 34 |
|
|
2024
Q4 | $325K | Hold |
79,000
| – | – | 0.17% | 46 |
|
|
2024
Q3 | $264K | Hold |
79,000
| – | – | 0.15% | 49 |
|
|
2024
Q2 | $235K | Sell |
79,000
-20,000
| -20% | -$59.6K | 0.15% | 52 |
|
|
2024
Q1 | $342K | Hold |
99,000
| – | – | 0.23% | 36 |
|
|
2023
Q4 | $133K | Sell |
99,000
-1,000
| -1% | -$1.34K | 0.09% | 72 |
|
|
2023
Q3 | $218K | Hold |
100,000
| – | – | 0.19% | 36 |
|
|
2023
Q2 | $239K | Buy |
+100,000
| New | +$239K | 0.2% | 34 |
|